U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional)

Due: Mar 12, 2025

$400,000

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to support research projects under Phase 3 of the U.S.-South Africa Program for Collaborative Biomedical Research. Research areas supported under this program include HIV/AIDS, HIV/AIDS co-morbidities and co-infections, HIV/AIDS-associated implementation science, and HIV/AIDS-associated data science. The hallmark of the U.S.-South Africa program is the development of collaborative partnerships between South African investigators and United States (U.S.) i...

Award Ceiling$400,000

Eligible Applicants- Others

Additional Eligibility Information

Other Eligible Applicants include the following:

Non-domestic (non-U.S.) Entities (Foreign Organizations); See funding opportunity for eligibility criteria. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

Funding TypeGrantCategories of Funding Activity- Education- Health- Income Security and Social ServicesOpportunity TypeDiscretionary

Grantor Contact InformationSee Section VII. Agency Contacts within the full opportunity announcement for all other inquires.Grantor Emailgrantsinfo@nih.govOther Grantor InformaitonNIH Grants Information<br/>grantsinfo@nih.gov

Additional informationhttps://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-023.htmlSupporting Linkhttp://grants.nih.gov/grants/guide/rfa-files/RFA-AI-24-023.html

U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional)

Start finding grants with Atom for

$0 today

$30 Billed monthly after 7-day trial. Cancel anytime.

Personalized grant emails delivered weekly, right to your inbox.

AI powered search engine with both keyword and semantic search capabilities.

Grant filters to find the perfect funding opportunities.